Keith Finlayson

2.4k total citations
38 papers, 1.9k citations indexed

About

Keith Finlayson is a scholar working on Molecular Biology, Atomic and Molecular Physics, and Optics and Cellular and Molecular Neuroscience. According to data from OpenAlex, Keith Finlayson has authored 38 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 9 papers in Atomic and Molecular Physics, and Optics and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in Keith Finlayson's work include Receptor Mechanisms and Signaling (9 papers), Atomic and Molecular Physics (8 papers) and Adenosine and Purinergic Signaling (6 papers). Keith Finlayson is often cited by papers focused on Receptor Mechanisms and Signaling (9 papers), Atomic and Molecular Physics (8 papers) and Adenosine and Purinergic Signaling (6 papers). Keith Finlayson collaborates with scholars based in United Kingdom, United States and Germany. Keith Finlayson's co-authors include John Sharkey, Louise Dickson, John Kelly, Jared W. Young, Hugh Marston, Christopher Spratt, Nicola Crawford, Lorraine E. Kerr, Donald J. Davidson and Deborah A. Sawatzky and has published in prestigious journals such as Physical Review Letters, The Astrophysical Journal and Journal of Materials Chemistry.

In The Last Decade

Keith Finlayson

38 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keith Finlayson United Kingdom 22 794 648 236 228 177 38 1.9k
Christopher T. Rodgers United Kingdom 34 420 0.5× 512 0.8× 336 1.4× 617 2.7× 911 5.1× 110 3.9k
Kenji Ishibashi Japan 23 227 0.3× 388 0.6× 132 0.6× 117 0.5× 48 0.3× 217 2.0k
W. J. Thompson United States 31 2.6k 3.3× 1.2k 1.9× 429 1.8× 131 0.6× 231 1.3× 109 4.6k
Christopher M. Anderson United States 36 1.5k 1.9× 1.9k 2.9× 824 3.5× 32 0.1× 99 0.6× 115 5.0k
Angelika Lampert Germany 30 1.5k 1.9× 944 1.5× 30 0.1× 205 0.9× 304 1.7× 111 2.7k
Mehran Salehpour Sweden 23 1.8k 2.3× 930 1.4× 32 0.1× 86 0.4× 381 2.2× 54 5.4k
Takashi Watanabe Japan 30 978 1.2× 957 1.5× 38 0.2× 31 0.1× 43 0.2× 133 4.4k
G. Casini Italy 36 1.3k 1.6× 928 1.4× 57 0.2× 124 0.5× 24 0.1× 202 3.8k
W. W. Morgan United States 34 950 1.2× 1.1k 1.8× 34 0.1× 81 0.4× 40 0.2× 188 4.5k
Michael E. Hildebrand Canada 27 947 1.2× 816 1.3× 27 0.1× 210 0.9× 107 0.6× 47 2.2k

Countries citing papers authored by Keith Finlayson

Since Specialization
Citations

This map shows the geographic impact of Keith Finlayson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith Finlayson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith Finlayson more than expected).

Fields of papers citing papers by Keith Finlayson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith Finlayson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith Finlayson. The network helps show where Keith Finlayson may publish in the future.

Co-authorship network of co-authors of Keith Finlayson

This figure shows the co-authorship network connecting the top 25 collaborators of Keith Finlayson. A scholar is included among the top collaborators of Keith Finlayson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith Finlayson. Keith Finlayson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Malhotra, Vikas, Farah Husain, Tom Quinn, et al.. (2023). Phase 2 randomised placebo-controlled trial of spironolactone and dexamethasone versus dexamethasone in COVID-19 hospitalised patients in Delhi. BMC Infectious Diseases. 23(1). 326–326. 2 indexed citations
2.
Humphries, Duncan C., Richard A. O’Connor, Tom Quinn, et al.. (2023). Specific in situ immuno-imaging of pulmonary-resident memory lymphocytes in human lungs. Frontiers in Immunology. 14. 1100161–1100161. 4 indexed citations
3.
Dickson, Louise & Keith Finlayson. (2008). VPAC and PAC receptors: From ligands to function. Pharmacology & Therapeutics. 121(3). 294–316. 296 indexed citations
4.
Thompson, Jane L., Keith Finlayson, D. Macdonald, et al.. (2008). Characterisation of the Bax-nucleophosmin interaction: the importance of the Bax C-terminus. APOPTOSIS. 13(3). 394–403. 19 indexed citations
5.
Young, Jared W., Lorraine E. Kerr, John Kelly, et al.. (2006). The odour span task: A novel paradigm for assessing working memory in mice. Neuropharmacology. 52(2). 634–645. 53 indexed citations
6.
Dickson, Louise, Ichiro Aramori, James McCulloch, John Sharkey, & Keith Finlayson. (2006). A systematic comparison of intracellular cyclic AMP and calcium signalling highlights complexities in human VPAC/PAC receptor pharmacology. Neuropharmacology. 51(6). 1086–1098. 70 indexed citations
7.
Young, Jared W., Nicola Crawford, John Kelly, et al.. (2006). Impaired attention is central to the cognitive deficits observed in alpha 7 deficient mice. European Neuropsychopharmacology. 17(2). 145–155. 185 indexed citations
8.
Dickson, Louise, Ichiro Aramori, John Sharkey, & Keith Finlayson. (2006). VIP and PACAP Receptor Pharmacology. Annals of the New York Academy of Sciences. 1070(1). 239–242. 19 indexed citations
9.
Young, Jared W., Keith Finlayson, Christopher Spratt, et al.. (2004). Nicotine Improves Sustained Attention in Mice: Evidence for Involvement of the α7 Nicotinic Acetylcholine Receptor. Neuropsychopharmacology. 29(5). 891–900. 174 indexed citations
10.
Finlayson, Keith, Harry J. Witchel, James McCulloch, & John Sharkey. (2004). Acquired QT interval prolongation and HERG: implications for drug discovery and development. European Journal of Pharmacology. 500(1-3). 129–142. 109 indexed citations
11.
Finlayson, Keith, et al.. (2003). Comparison of effects of MgCl2 and Gpp(NH)p on antagonist and agonist radioligand binding to adenosine A1 receptors.. PubMed. 24(8). 729–40. 4 indexed citations
12.
Finlayson, Keith, et al.. (2001). [3H]Dofetilide binding in SHSY5Y and HEK293 cells expressing a HERG-like K+ channel?. European Journal of Pharmacology. 412(3). 203–212. 32 indexed citations
13.
Finlayson, Keith, et al.. (2001). Characterisation of [125I]-apamin binding sites in rat brain membranes and HEK293 cells transfected with SK channel subtypes. Neuropharmacology. 41(3). 341–350. 24 indexed citations
14.
Finlayson, Keith, et al.. (2001). [3H]Dofetilide binding to HERG transfected membranes: a potential high throughput preclinical screen. European Journal of Pharmacology. 430(1). 147–148. 102 indexed citations
15.
Butcher, Steven P., et al.. (1999). Pyrazolopyridine derivatives act as competitive antagonists of brain adenosine A1 receptors: []GTPγS binding studies. European Journal of Pharmacology. 365(2-3). 309–315. 9 indexed citations
16.
Marston, Hugh, Keith Finlayson, Henry J. Olverman, et al.. (1998). Pharmacological Characterization of a Simple Behavioral Response Mediated Selectively by Central Adenosine A1 Receptors, Using In Vivo and In Vitro Techniques. Journal of Pharmacology and Experimental Therapeutics. 285(3). 1023–1030. 53 indexed citations
17.
Finlayson, Keith, et al.. (1997). Species differences in brain adenosine A1 receptor pharmacology revealed by use of xanthine and pyrazolopyridine based antagonists. British Journal of Pharmacology. 122(6). 1202–1208. 51 indexed citations
18.
Finlayson, Keith, Steven P. Butcher, John Sharkey, & Henry J. Olverman. (1997). Detection of adenosine receptor antagonists in rat brain using a modified radioreceptor assay. Journal of Neuroscience Methods. 77(2). 135–142. 17 indexed citations
19.
Briand, J. P., P. Charles, D. D. Dietrich, et al.. (1993). Hyperfine quenching and measurement of the 23P0–23P1fine-structure splitting in heliumlike silver (Ag45+). Physical Review A. 47(4). R2454–R2457. 46 indexed citations
20.
Marrus, Richard, Alexandre Simionovici, P. Indelicato, et al.. (1989). Measurement of the (1s)(2p1/2)23P0-(1s)(2p1/2)23P1fine-structure splitting in heliumlikeAg45+. Physical Review Letters. 63(5). 502–504. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christopher T. Rodgers Breakdown of academic impact, for papers by Kenji Ishibashi Breakdown of academic impact, for papers by W. J. Thompson Breakdown of academic impact, for papers by Christopher M. Anderson Breakdown of academic impact, for papers by Angelika Lampert Breakdown of academic impact, for papers by Mehran Salehpour Breakdown of academic impact, for papers by Takashi Watanabe Breakdown of academic impact, for papers by G. Casini Breakdown of academic impact, for papers by W. W. Morgan Breakdown of academic impact, for papers by Michael E. Hildebrand
Rankless by CCL
2026